Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
compound azintamide enteric-coated tablets
- Development stage
- Phase 4
- Lead developer
- Xinhua Hospital
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Oral
01
Overview
**Compound azintamide enteric-coated tablets** is an oral fixed-dose digestive drug product marketed in China as **Mite**. Each enteric-coated tablet contains azintamide, pancreatin, cellulase, and simethicone. Azintamide is a choleretic agent that promotes bile secretion; pancreatin supplies digestive amylase, protease, and lipase activities; cellulase supports degradation of plant-cell-wall material; and simethicone reduces gastrointestinal gas by an antifoaming action. The product is used for dyspeptic symptoms associated with inadequate bile secretion or digestive-enzyme deficiency and has been evaluated in a Phase 4 study of dyspepsia after laparoscopic cholecystectomy.
- Brand names
- Mite泌特
- Other names
- Compound Azintamide Enteric-coated TabletsFufang Aqinmite Changrongpian复方阿嗪米特肠溶片
02
Targets
CellulasePNLIP (Pancreatic triacylglycerol lipase)AMY (Pancreatic alpha-amylase)
Beyond the preview
Go deeper on compound azintamide enteric-coated tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on compound azintamide enteric-coated tablets.